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Background: Antimicrobial resistance rates are increasing. This is, among others,
caused by incorrect or inappropriate use of antimicrobials. To target this, a
multidisciplinary antimicrobial stewardship-team (A-Team) was implemented at the
University Medical Center Groningen on a urology ward. Goal of this study is to evaluate
the clinical effects of the case-audits done by this team, looking at length of stay (LOS)
and antimicrobial use.
Methods: Automatic e-mail alerts were sent after 48 h of consecutive antimicrobial
use triggering the case-audits, consisting of an A-Team member visiting the ward,
discussing the patient’s therapy with the bed-side physician and together deciding on
further treatment based on available diagnostics and guidelines. Clinical effects of the
audits were evaluated through an Interrupted Time Series analysis and a retrospective
historic cohort.
Results: A significant systemic reduction of antimicrobial consumption for all patients
on the ward, both with and without case-audits was observed. Furthermore, LOS for
patients with case-audits who were admitted primarily due to infections decreased
to 6.20 days (95% CI: 5.59–6.81) compared to the historic cohort (7.57 days; 95%
CI: 6.92–8.21; p = 0.012). Antimicrobial consumption decreased for these patients
from 8.17 DDD/patient (95% CI: 7.10–9.24) to 5.93 DDD/patient (95% CI: 5.02–6.83;
p = 0.008). For patients with severe underlying diseases (e.g., cancer) these outcome
measures remained unchanged.
Conclusion: The evaluation showed a considerable positive impact. Antibiotic use of
the whole ward was reduced, transcending the intervened patients. Furthermore, LOS
and mean antimicrobial consumption for a subgroup was reduced, thereby improving
patient care and potentially lowering resistance rates.
Keywords: A-Teams, antimicrobial prescription, antimicrobial stewardship, antimicrobial resistance, intervention
study
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Introduction
Antimicrobial resistance is a world-wide problem. Suboptimal
prescription and subsequent inappropriate use of antimicrobials
contributes to increasing development of resistance (Goossens,
2009; Tacconelli et al., 2009). The optimization of antimicrobial
therapy in hospitalized patients is therefore an urgent global
challenge (World Health Organization, 2012; Bartlett et al.,
2013). Urology departments are even more vulnerable because
of a high number of (high risk) gram-negative bacteria species
encountered (Wagenlehner et al., 2013). Several aspects regarding
antimicrobial therapy such as choice of drug (and spectrum),
duration, mode of administration and dosage should be subject
for improvement (Braykov et al., 2014). This is also true for
countries with a relatively low antimicrobial prescription rate and
low resistance rates, such as the Netherlands (de Kraker et al.,
2013; European Centre for Disease Prevention, 2013). Therefore,
Dutch government has made an antimicrobial stewardship
program (ASP) with A-Teams mandatory for every hospital from
January 2014 (SWAB, 2012).
Antimicrobial stewardship addresses many aspects of
infection management, of which one is audit and feedback of the
therapy (Davey et al., 2013). In recent years this has proven to
improve on the appropriateness of antimicrobial therapy (Senn
et al., 2004; Pulcini et al., 2008; Cisneros et al., 2014; Liew et al.,
2015). At the University Medical Center Groningen (UMCG) in
the Netherlands, this case-audit is combined with face-to-face
consultation on day 2. The goal is to optimize and streamline the
antimicrobial therapy as early as possible using microbiological
diagnostics, thereby improving patient care. Face-to-face
consultations are used explicitly to create an eﬀective learning
moment for prescribing physicians (Lo-Ten-Foe et al., 2014).
The aim of this study is evaluating this implemented A-Team
on a urology ward in an academic hospital setting, focusing on
two clinical outcome measures: antimicrobial use and length of
stay (LOS). Because there are considerable risks of acquiring
a nosocomial infection with each extra day of hospitalization
(Rhame and Sudderth, 1981) and acquiring a catheter-related
infection with each extra day of an intravenous line (Sevinç
et al., 1999; Chopra et al., 2013), changes in LOS and/or
antimicrobial administration can have a large impact on the
quality of care and patient safety. The direct return on investment
for this A-Teamhas already been extensively evaluated separately,
using the same patient groups, and found to be positive
(Dik et al., 2015a). The clinical outcome measures in this
study have been evaluated through an interrupted time-series
analysis as well as through a quasi-experimental set-up, thereby
providing an extensive evaluation of a set of clinically relevant
parameters.
Materials and Methods
The study was performed at a 20-bed urology ward in a
large 1339-bed academic hospital in the northern part of the
Netherlands from June 16th 2013 to June 16th 2014. Inclusion
of patients for the A-Team was done using a clinical rule
program (Gaston, Medecs BV, Eindhoven, the Netherlands).
The applied algorithm selected patients who received 48 h of
selected antimicrobials (Supplementary Table S1). These were
chosen based upon in-house evaluation of consumption at the
ward and their respective risk for resistance development in
general. In total 72% of the prescriptions for this ward was
covered, including all drugs recommended in the applicable
guidelines for the included patients. The clinical rule program
automatically sends an email alert to the A-Team members
(day 2), which contains the patient hospital ID, prescription
details (e.g., administered antimicrobials, dosage, and start date
[day 0]). It also includes clinical chemistry data (ALAT, ASAT,
CRP, leucocytes, and creatinine). Microbiological diagnostic
reports were collected manually. The hypothesis was that in
the majority of the cases microbiologic diagnostic results will
be (partly) available at day 2, and can thus be used during
the case-audit. Furthermore, all A-Team members had access
to all available microbiological data, including not yet ﬁnally
authorized data (i.e., samples still being processed). Patients
whose antimicrobial therapy started within 3 days after admission
were included in the evaluation.
The A-Team is multi-disciplinary consisting of clinical
microbiologists, infectious disease physicians, and hospital
pharmacists. It reports to the hospital’s Antimicrobials
Committee and Infection Prevention Committee, which
have a mandate from the board of directors to implement
and run the ASP. It is an integral part of one of the “leading
coalitions” within the hospital to improve patient safety and
quality of care. One A-Team member (clinical microbiologist
or infectious disease physician) visited the ward after being
triggered by the email alert and discussed antibiotic therapy
with the bed-side physician(s) face-to-face. Consensus on the
continuation of the treatment is one of the main goals. During
the case-audit, the therapy was discussed and the available
diagnostics were reviewed. Using the expertise and experience
of both the A-Team member and the bed-side physician a
decision on the continuation of the antimicrobial therapy was
made. Decisions were always made based on local guidelines
for urological infections, which in turn are based on national
and European guidelines (Geerlings et al., 2013; Grabe et al.,
2013). In the end, agreed-on interventions were scored. The
chosen interventions were based upon a previous pilot in the
same hospital (Supplementary Table S2; Lo-Ten-Foe et al.,
2014).
Compliance was assessed at day 30. If the agreed-on
intervention was followed by the appropriate action within 24 h,
it was scored as compliant.
Evaluation of practice was the main goal of this study,
focussing on a change in antimicrobial consumption and a
reduction in LOS. Based upon the pilot study (Lo-Ten-Foe et al.,
2014), a reduction of at least 1 day was our pre-determined
goal. A ﬁnancial evaluation of the same group of patients and
using the same historic cohort was already performed (Dik
et al., 2015a). Implementation of the A-Team is part of a local
hospital-wide ASP, which is being developed keeping in mind
recommendations done by the IDSA/SHEA and the ESGAP
(Keuleyan and Gould, 2001; Dellit et al., 2007).
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Historic Control Cohort
For evaluation of the clinical eﬀects, a frequency based historic
control cohort was compiled. The control cohort consisted of
patients who stayed at the same ward in a 30-months period prior
to the intervention. Diagnosis Related Group (DRG) codes from
the patients in the intervention group and the consumption of
>48 h of the alert antimicrobials (Supplementary Table S1) were
used to ﬁlter the control cohort. DRG codes were assigned to the
patient after discharge for insurance purposes by a grouper, based
upon scored procedures1. Patients’ antimicrobial consumption
was measured in DDDs per 100 patient days, as stated by the
WHO2.
The described case-audit was normal every day care
implemented within the hospital and approved by the
Antimicrobials Committee, following national guidelines.
This study was of an observational nature, evaluating
the newly implemented procedures. Data was collected
retrospectively from the hospital’s data warehouse; it was
anonymous, partly aggregated and did not contain any directly
or indirectly identiﬁable personal details. Following Dutch
legislation and guidelines of the local ethics committee, formal
ethical approval was therefore not required3.
Subgroup Analysis
After explorative analysis of the data two subgroups were
compiled to correct for the modifying eﬀect of the patients’
indication. The two groups were stratiﬁed by DRG codes. The
ﬁrst group (Group 1) consisted of patients without severe
underlying diseases and whose infection was the most likely
major problem and the main driver for LOS. The second group
(Group 2) consisted mainly of oncology and transplantation
patients. Here the underlying problem (e.g., cancer) was the most
likely driver for LOS, rather than the infection.
Statistical Analysis
For antibiotic consumption of the total ward, including patients
without intervention(s), an interrupted time-series analysis was
performed. For subgroup analysis, unpaired t-tests, chi square
tests and Kaplan–Meier survival plots with a log-rank test were
applied, as appropriate. Signiﬁcance threshold was p < 0.05. For
subgroup analyses, a threshold of p < 0.025 was set in order to
account for possible family wise error rates. Analysis was done
with IBM SPSS Statistics 20 (IBM, Armonk, NY, USA) after
1 year.
Results
Consulted Patients
During the 1-year study period, 1298 patients were admitted to
the urology ward. 850 received at least one dose of antimicrobials.
114 alert patients were included in this study (61% male; mean
age 62 years male, 50 years female; Table 1). They received a total
1http://www.DBConderhoud.nl
2http://www.whocc.no/atcdddindex
3http://www.ccmo.nl/en
TABLE 1 | Patient baseline characteristics.
Intervention group Control group p-value
Total group N = 114 N = 357
Male 61% 69% 0.11a
Mean age 57.51 (±2.95) years 61.52 (±1.72) years 0.01b,c
Group 1 N = 70 (61%) N = 209 (59%)
Male 51% 60% 0.11a
Mean age 55.25 (±3.71) years 59.35 (±2.25) years 0.046b
Group 2 N = 44 (39%) N = 148 (41%)
Male 75% 84% 0.71a
Mean age 61.12 (±4.79) years 64.57 (± 2.62) years 0.14b
Included patients and the control group patients’ characteristics and their
respective p-values. 95% Confidence intervals are shown in brackets, when
applicable. Characteristics are given for the total group, as well as for the
two subgroups. Group 1 consisted mainly of patients without severe underlying
diseases, and Group 2 consisted of patients with severe underlying diseases.
aChi square test; bMann–Whitney U-Test; cTotal group was not used further in
calculations.
The difference in age and sex showed no significant influence on the outcome
measures.
of 126 case-audits (including 12 follow-up consults), resulting in
166 interventions. Consensus was reached in 97.6% of the cases
(n = 123) and the compliance (i.e., action within 24 h) was 92.1%
(n = 116). Case-audits took on average between 10 and 15 min,
including administration time.
Results of Microbiological Diagnostics were
Mostly Available on Day 2
In 86.0% (n= 98) of the alert patients microbiological diagnostics
had been initiated, in 50.0% (n = 57) this was done on day 0 or
24 h prior to starting antimicrobials. At the ﬁrst case-audit (day 2)
results were (partly) available (gram staining, incomplete culture
data) in 72.8% (n = 83) of the cases.
A Large Majority of the Consulted Patients
Received Interventions
Of the patients who were consulted, there was an alteration
of the therapy (any intervention besides ‘continue’ at the ﬁrst
case-audit) in 74.7% of the patients. In 23.7% (n = 27; 16.3%
of total interventions) treatment was stopped. A switch to oral
treatment was performed in 23.7% (n = 27; 16.3% of total
interventions). 21.9% (n = 25; 15.1% of total interventions)
received a diﬀerent antimicrobial, dosage was optimized in 4.4%
(n = 5; 3.0% of total interventions) and treatment de-escalated in
15.8% (n = 18; 10.8% of total interventions). For 8.8% (n = 10;
6.0% of total interventions) there another intervention (e.g., add
an antimicrobial, perform extra diagnostics) was performed (see
Figure 1 for the stratiﬁcation of interventions per subgroup).
Prescribing Trends of the Whole Ward
Changed after Implementation
Most notably, the positive eﬀect transcended the target group
on this ward. The trend of antimicrobial consumption of all
patients admitted to the ward (17.3% intervened and 82.7%
not intervened) changed after start of the intervention. Using
an interrupted time-series analysis there was an observed drop
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FIGURE 1 | Interventions performed. Distribution of the interventions performed for alert patients, subdivided into the two Groups. Percentages of interventions
refer to the total number done within the 75% of intervened patients, where one patient can receive multiple interventions.
of 25.0% after 1 month (p = 0.012), 23.6% at 6 months
(p = 0.007), and 22.4% at 12 months (p = 0.047), compared
to expected usage, based upon the extrapolated pre-intervention
data (Figures 2A,C).
The mean percentage of antimicrobial recipients per month
in relation to the total number of patients dropped by 7.3% at
1 month (p= 0.131), 10.4% at 6 months (p= 0.018) and 12.8% at
12 months (p = 0.024), compared to the expected percentage of
recipients (Figures 2A,B).
Length of Stay was Significantly Reduced for
Group 1 Patients
Length of stay was evaluated for the two subset groups to take into
account the modifying eﬀect of the patients’ indication. Group
1, without severe underlying diseases, showed an average LOS
reduction of 1.46 days compared to the control group (6.20 days;
95% CI: 5.59–6.81 vs. 7.57 days; 95% CI: 6.92–8.21; p = 0.012;
Figure 3A). LOS for patients of Group 2, with severe underlying
disease had a minor but non-signiﬁcant increase compared to
the control group (8.36 days; 95% CI: 7.10–9.62; vs. 8.10 days;
95% CI: 7.24–8.97; p= 0.801; Figure 3B). Patients’ LOS remained
the same for patients who stayed at the department and did not
receive an intervention (3.95 days; 95% CI: 3.75–4.16) compared
to 1 year earlier (3.96 days; 95% CI: 3.71–4.21; p = 0.581).
Antimicrobial Consumption was Lower for
Group 1 Patients
Overall antimicrobial consumption dropped by 2.24 DDD per
patient for Group 1 (p = 0.008). There was a trend to lower
intravenous administration (67%, compared to 69% in the
control cohort; p = 0.099). For Group 2 there was a non-
signiﬁcant drop of 0.91 DDD per patient (p = 0.712; Table 2).
Discussion
The main goal of this study was to evaluate an already
implemented A-Team and the eﬀects of its case-audits, by looking
both at LOS and DDDs. These parameters were taken as main
outcome measures, because they are known to have a major
impact on the quality of care, and they are aﬀected by an ASP
(Davey et al., 2013). The A-Team reviewed antimicrobial therapy
on day 2, thus, making optimal use of available (microbiological)
diagnostics. By means of the automatic alert (which can be
modiﬁed for speciﬁc groups of patients, departments, and
speciﬁc antimicrobials) face-to-face case-audit on the ward was
encouraged and facilitated by providing an easy overview of
relevant patient information. Objective of the case-audit was
to reach a consensus-based agreement between the A-Team
member and the physician at the ward, using (local) guidelines,
available diagnostics and the expertise and experience of both
physicians. This should optimize antimicrobial treatment. The
case-audit focused on the improvement of patient care through
relatively easy to achieve improvements after only 48 h of therapy,
such as an early IV-PO switch, and stopping therapy when
there was no longer an indication. Furthermore, the bed-side
physicians anticipated the A-Team visits. These provided an extra
opportunity for questions about appropriateness of therapy and
requesting additional consultations for further patients on the
ward. This resulted in 19 additional patients discussed during
the evaluation period. These patients had not triggered an alert,
for example because therapy was still less than 48 h or because
therapy had not even been started. Twelve patients received more
than one case-audit. These follow up audits were often deemed
necessary because culture results were not completely available.
Very unexpectedly, and unlike previously published in other
studies, we found a considerable signiﬁcant additional positive
eﬀect on the antimicrobial consumption of the whole ward.
With consultation of 17.3% of the patients at the ward during
the evaluation period, we saw a broad eﬀect on all patients,
including those without any consultations or intervention(s).
The drop in the rate of patients receiving antimicrobials and
the drop in DDDs per patient has been very likely due to
the continuing educational eﬀect of the consensus-based case-
audit where face-to-face information exchange is taking place.
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FIGURE 2 | Antimicrobial stewardship-team (A-Team) effects on the
whole ward. (A) trends of percentages of all patients on the ward
receiving antibiotics with and without intervention(s) and respective DDDs
per 100 patient days. Shown are 2 years before the intervention started
(June 2013), until June 2014, including trend lines and predicted trend
lines. A second dotted trend line for the mean DDDs depicts the trend
without the outlier patient from April 2014 (∗). (B) predicted and
measured percentages of users at three different time points with their
respective p-values, calculated with an interrupted time series analysis.
(C) predicted and measured consumption with their respective p-values,
on the same three time points with the same interrupted time series
analysis. (∗) The peak in the month April is caused by a single patient
who received correct but extensive small spectrum oral antibiotic
treatment for a deep-seated, complicated infection.
Although antimicrobial consumption of the whole ward would
be directly aﬀected by interventions, the percentage of recipients
should not change. This strengthens the conclusion that the
A-Team presence at the ward had an eﬀect transcending the
group of intervened patients. The knowledge that antimicrobial
use is monitored and evaluated will most likely contribute to a
higher awareness by the prescribing physicians, thereby possibly
creating a kind of Hawthorne eﬀect (Mangione-Smith et al.,
2002). Going to wards to discuss patients requires investment
of staﬀ time. However, it should be noted that for this ward,
on average only 10–15 min were spent per case-audit by an
A-Team member, including administration. It was not the goal
to discuss every patient with antimicrobial therapy. A large
majority of patients received prophylactic therapy of which the
duration should be less than 48 h (often just a single shot)
and where an intervention would not achieve a lot of eﬀect.
The quality of economic analyses of ASPs is often sub optimal,
due to insuﬃcient outcome measures and performed methods
(Dik et al., 2015b). Therefore, a more extensive and thorough
economical analysis has been also undertaken for the same
patients and using the same historic cohort. Mainly due to the
decrease in LOS for the group of patients primarily admitted due
to an infection, the implementation of the A-Team had a positive
direct return on investment (Dik et al., 2015a).
Automatic email alerts can be easily adjusted to the speciﬁc
needs of a hospital or ward, depending on local challenges and
required goals (e.g., IV-PO switch, review of only restricted
antimicrobials, only one ward or the whole hospital, children,
or adults, and at a timeframe of choice), making it a relatively
simple method to keep track of patients receiving (selected)
antimicrobials. We estimated that implementation of this speciﬁc
program for the whole hospital would require 2–3 fte A-Team
specialists.
The large number of performed interventions shows that
implementing an A-Team was highly relevant. Indeed, frequent
non-optimal antimicrobial treatment of urology patients has
been shown earlier (Hecker et al., 2014). Antimicrobial treatment
can be improved also in other patient populations (Braykov
et al., 2014). In line with our results, an audit and feedback
of therapy after 48 h has been recently shown to be fruitful in
a hospital-wide setting (Liew et al., 2015). However, this study
did not show a reduced LOS as a beneﬁt. Although diﬃcult to
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FIGURE 3 | Kaplan–Meier plots of length of stay (LOS). Percentages of patients’ days of discharge. Group 1 intervention patients compared to the historic
cohort group 1 (A) with Group two patients as insert (B). Significance was tested with a Log–Rank test (Mantel–Cox).
TABLE 2 | Effects of the Antimicrobial Stewardship-Team (A-Team)
interventions on antibiotic use (DDD per patient).
Intervention
group
Control
group
Difference p-value
Group 1 N = 70 N = 209
Overall DDDs 5.93 (±0.90) 8.17 (±1.07) −27.5% 0.008
PO DDDs 1.95 (±0.52) 2.51 (±0.44) −22.3% 0.849
IV DDDs 3.97 (±0.93) 5.66 (1.05) −29.8% 0.099
Group 2 N = 44 N = 148
Overall 7.21 (±1.47) 8.13 (±1.11) −11.2% 0.712
PO 2.98 (±0.92) 2.81 (±0.59) 5.9% 0.931
IV 4.20 (±1.36) 5.31 (±0.95) −20.3% 0.738
Antibiotic consumption compared between the intervention group and the historic
control cohort for Group 1 and Group 2. Consumption is presented as mean DDDs
per patient, the difference between the intervention and control in percentages
and 95% CI in brackets. All tests were unpaired, two-tailed t-tests performed on
log-transformed data.
compare due to the diﬀerent setting, the higher availability of
microbiological diagnostics in our patients might account for the
diﬀerences in LOS. Furthermore, patient it is important to take
the characteristics of the patient group into account.
Here, we observed that the interventions resulted in a
reduced average LOS for a subgroup of patients and a global
drop in antimicrobial DDDs. This ﬁnding underscores that a
substantial proportion of patients can be switched earlier to oral
administration or stopped completely, an easily achievable target,
the “low hanging fruits” (Goﬀ et al., 2012). The IV-PO switches
also explain why oral administration did not change signiﬁcantly.
However, the eﬀects on oral DDDs might even be larger, because
23% of the IV to PO switch patients was sent home directly after
the switch without getting inpatient oral therapy. Consequently,
they did not count for the calculation of mean DDDs for PO
treatment.
By lowering LOS and DDDs the risks for hospital
acquired infections, catheter-related infections and resistance
development should also be lower, thereby improving patient
care and safety (Rhame and Sudderth, 1981; Sevinç et al., 1999;
Chopra et al., 2013). However, the current time-frame of the
study is too short to measure these eﬀects and they are thus to
be investigated in the coming years. Other outcome measures,
notably duration of therapy in days and re-admissions rates
were not signiﬁcantly altered (data not shown). If an ASP were
implemented for more complex patients (e.g., on an ICU), it
would also be important to take morbidity and/or complications,
and mortality into account, because these outcome measures can
be expected to aﬀect mainly more complex patients.
It is important to note that LOS may not be taken as a
universal outcome measure or quality indicator for an ASP. As
we conclusively show, a day 2 bundle will not lower the LOS
for all patients. Especially in an academic hospital there are
many referral patients with severe oncology or transplant surgery
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indications. If these patients subsequently develop an infection,
the driver for the LOS and/or their antimicrobial use is most
likely the underlying disease and a decrease in outcome measures
such as LOS can thus not be expected. This fact could also
explain ambiguous results on patients’ LOS seen in the Cochrane
Review (Davey et al., 2013). Consequently, this point should be
taken into account for the design and analyses of future ASP
studies. Finally, it should be noted that the success of the program
is not determined by a decrease in LOS or DDDs. The main
goal was to improve the quality of care by adjusting therapy as
quickly as possible according to the diagnostic results. This had
an eﬀect on LOS and DDDs on a subgroup of patients. Of note,
this does not imply that the intervention failed in patients of
group 2. Rather, this suggests that outcome measures to monitor
success of an ASP have to be chosen wisely. Possible (in)direct
eﬀects extend much further, such as a lower risk of resistance
and better quality of care for the patients due to a more optimal
antimicrobial treatment. However, these outcome measures are
diﬃcult to measure objectively, especially on the short term in a
retrospective set-up.
Our study has some limitations. Eﬀects of the A-Team
were evaluated for a urology ward in an academic setting. To
investigate eﬀects in diﬀerent settings reliably, further studies
are needed. Possible confounders with an eﬀect on the LOS
due to the quasi-experimental set-up and the chosen cohort
might have been present, rendering ASP studies complicated to
perform (Marwick and Nathwani, 2014). This study evaluated
the eﬀects of an already implemented intervention. Performing
a (randomized) controlled trial was therefore neither an option
nor a goal. Analyses were done within subgroups, to exclude
modifying eﬀects of the underlying disease. Without such a sub
analysis, eﬀects would be averaged out and lost. During the
study period no other additional measures were performed to
inﬂuence antimicrobial prescriptions or reduce LOS (i.e., changes
in formularia, additional education or changes in restriction of
antimicrobials). For antimicrobial consumption seasonal eﬀects
were ruled out by looking back 2 years. The distribution of
age and sex was not optimal, but no correlation or eﬀect was
found on LOS or antibiotic use. The fact that the LOS of
Group 2 did not change signiﬁcantly provides an extra internal
negative control. Unfortunately, not all information was available
for evaluation (possible co-morbidities were not available as
objective, measurable data).
We conclude that ASP interventions should be further
encouraged. Inappropriate use of antimicrobials contributes to
higher resistance rates, making infections even more diﬃcult to
treat (Burke and Yeo, 2004). Recently a Dutch multicenter study
showed that appropriateness of antimicrobial therapy in UTI
patients has a positive impact on the LOS (Spoorenberg et al.,
2014), supporting our ﬁndings that the A-Team interventions
successfully optimized therapy thereby reducing the LOS. Even
though A-Teams cost money to implement, the reduction in
LOS for some patients provides enough beneﬁts to provide a
positive return on investment (Dik et al., 2015a). Pro-active
collaboration between the treating medical specialty, medical
microbiology, infectious diseases, and pharmacy departments
via a day-2 evaluation of antimicrobial therapies could be
used to provide beneﬁt for patients in other hospitals, as
well.
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